Angiotensin enzyme inhibitors and angiotensin receptor blockers as protective factors in COVID-19 mortality: a retrospective cohort study

Targeting the renin-angiotensin system is proposed to affect mortality due to coronavirus disease 2019 (COVID-19). We aimed to compare the mortality rates in COVID-19 patients who received angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEIs/ARBs) and those who did not. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Yahyavi, Ashkan, Hemmati, Nima, Derakhshan, Pegah, Banivaheb, Behrooz, Karimi Behnagh, Arman, Tofighi, Rozhin, TehraniYazdi, Alireza, Kabir, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Im - Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576108/
https://www.ncbi.nlm.nih.gov/pubmed/33085063
http://dx.doi.org/10.1007/s11739-020-02523-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576108/
https://www.ncbi.nlm.nih.gov/pubmed/33085063
http://dx.doi.org/10.1007/s11739-020-02523-9

Ejemplares similares